secwatch.observer — SEC 8-K summary
======================================

Issuer:     Embecta Corp. (EMBC)
CIK:        0001872789
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001872789-24-000016
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Embecta Q2 revenue up 3.6% to $287.2M; raises FY2024 guidance above prior range
-------------------------------------------------------------------------------

- Revenue of $287.2M (+3.6% reported, +4.5% constant currency); U.S. +0.8%, International +6.8%.
- Adjusted EPS of $0.67 vs $0.75 prior year; adjusted operating margin of 26.1% vs 30.6%.
- Raised FY2024 guidance: revenue $1,111-1,116M (prev. $1,094-1,116M), adj. EPS $2.20-2.30 (prev. $1.95-2.15).
- FDA continues review of insulin patch pump 510(k); ERP implementation covers ~85% of revenue.
- Declared quarterly dividend of $0.15/share, payable June 14, 2024 to holders of record May 28, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1872789/000187278924000016/0001872789-24-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1872789/000187278924000016/embc-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001872789-24-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer